BRCA2 and ovarian carcinoma: A total of 657 pathogenic variants were identified in these genes, with a significant predominance in BRCA1. The most affected exons were exon 10 for BRCA1 and exon 11 for BRCA2, which are important due to their association with susceptibility regions for breast and ovarian cancer.